Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer.
Cell Rep Med
; 1(8): 100131, 2020 11 17.
Article
in En
| MEDLINE
| ID: mdl-33294856
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Proto-Oncogene Proteins p21(ras)
/
Mitogen-Activated Protein Kinase Kinases
/
MAP Kinase Signaling System
/
Mechanistic Target of Rapamycin Complex 1
/
Mechanistic Target of Rapamycin Complex 2
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Cell Rep Med
Year:
2020
Document type:
Article
Affiliation country:
Canada
Country of publication:
United States